National Cancer Institute; Notice of Meeting, 60542 [05-20755]

Download as PDF 60542 Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Advisory Committee to the Director, National Cancer Institute. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Advisory Committee to the Director, National Cancer Institute. Date: October 31, 2005. Time: 11 a.m. to 11:45 a.m. Agenda: The purpose of the meeting will be to review the key Sarcoma PRG recommendations. Place: National Institutes of Health, National Cancer Institute, 31 Center Drive, Room 11A48, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Cherie Nichols, Director of Science Planning and Assessment, National Cancer Institute, National Institutes of Health, Building 6116, Room 205, Bethesda, MD 20892, (301) 496–5515. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/joint/htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 4, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–20755 Filed 10–17–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as 17:22 Oct 17, 2005 Name of Committee: Sickle Cell Disease Advisory Committee. Date: November 7, 2005. Time: 8:30 a.m. to 4 p.m. Agenda: Discussion of Program policies and issues. Place: National Institutes of Health, 6701 Rockledge Drive, Room 9112, Bethesda, MD 20892. Contact Person: Robert B. Moore, PhD, Health Scientist Administrator, Blood Diseases Program, Division of Blood Disease and Resources, National Heart, Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 10162, Bethesda, MD 20892, 301/435– 0050. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). Dated: October 6, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–20730 Filed 10–17–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–M VerDate Aug<31>2005 amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Jkt 208001 National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Research Scientist Development Awards (K01s). Date: November 3–4, 2005. Time: 6 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: Zoe Huang, MD, Health Scientist Administrator, Review Branch, Room 7190, Division of Extramural Affairs, National Heaart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892–7924, 301–435–0314, huangz@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Innovative Technologies for Engineering Small Blood Vessels. Date: November 9, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, MD 21044. Contact Person: David A. Wilson, PhD, Scientific Review Administrator, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7204, MSC 7924, Bethesda, MD 20892, 301/435–0929. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Research Program Project Applications (PO1s). Date: November 14, 2005. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, MD 21044. Contact Person: Valerie L. Prenger, PhD, Scientific Review Administrator, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7214, Bethesda, MD 20892–7924, (301) 435– 0270. prengerv@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 3, 2005. Anthony M. Coelho, Jr. Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–20751 Filed 10–17–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 70, Number 200 (Tuesday, October 18, 2005)]
[Notices]
[Page 60542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20755]



[[Page 60542]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Advisory Committee to the Director, National Cancer Institute.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National 
Cancer Institute.
    Date: October 31, 2005.
    Time: 11 a.m. to 11:45 a.m.
    Agenda: The purpose of the meeting will be to review the key 
Sarcoma PRG recommendations.
    Place: National Institutes of Health, National Cancer Institute, 
31 Center Drive, Room 11A48, Bethesda, MD 20892, (Telephone 
Conference Call).
    Contact Person: Cherie Nichols, Director of Science Planning and 
Assessment, National Cancer Institute, National Institutes of 
Health, Building 6116, Room 205, Bethesda, MD 20892, (301) 496-5515.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/joint/htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-20755 Filed 10-17-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.